Clinical Trials on Bladder Substitution in United Kingdom
Total 1496 results
-
PfizerCompletedOveractive Bladder (OAB) With Symptoms of Frequency, Urgency, and UrgencyUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG Oncology; Eastern Cooperative Oncology GroupCompletedBladder CancerUnited States
-
Rajeev ChaudhryWithdrawn
-
Cleveland Clinic FloridaAstellas Pharma US, Inc.Terminated
-
University Hospitals Cleveland Medical CenterWithdrawnOveractive BladderUnited States
-
Loyola UniversityAstellas Pharma US, Inc.Completed
-
TriHealth Inc.CompletedOveractive BladderUnited States
-
Massachusetts General HospitalAstellas Pharma IncCompletedOveractive BladderUnited States
-
Walter Reed National Military Medical CenterUnknownOveractive BladderUnited States
-
Christopher J Chermansky, MDTerminated
-
Weill Medical College of Cornell UniversityNaturex-DbsCompletedOveractive BladderUnited States
-
Weill Medical College of Cornell UniversityPfizerCompletedBladder Outlet ObstructionUnited States
-
Weill Medical College of Cornell UniversityLaborie Medical Technologies Inc.; Urodynamix TechnologiesCompleted
-
Miami VA Healthcare SystemPfizerCompletedOveractive BladderUnited States
-
University of VirginiaCompletedBladder CancerUnited States
-
University of California, IrvineCompletedOveractive BladderUnited States
-
Istari Oncology, Inc.Active, not recruitingSolid Tumor | Bladder Cancer | Non-muscle-invasive Bladder CancerUnited States
-
University of Kansas Medical CenterCompletedBladder CancerUnited States
-
University of OklahomaNational Cancer Institute (NCI)Completed
-
Edward MessingImagin MedicalCompleted
-
University of MichiganCompletedBladder CancerUnited States
-
University of SalfordUnknownPelvic Organ Prolapse | Cystocele | Uterine Prolapse | Rectocele | Anterior Wall; Prolapse, Vaginal | Posterior Wall; Prolapse, Vaginal | Vault Prolapse, VaginalUnited Kingdom
-
Baylor College of MedicineRecruitingBladder CancerUnited States
-
University of Alabama at BirminghamTerminatedOveractive BladderUnited States
-
M.D. Anderson Cancer CenterBristol-Myers SquibbTerminatedBladder CancerUnited States
-
The Cleveland ClinicPfizerUnknown
-
M.D. Anderson Cancer CenterAstraZenecaTerminatedBladder CancerUnited States
-
Bay State Clinical Trials, Inc.TerminatedOveractive BladderUnited States
-
Matthew GalskyNovartisTerminatedBladder Cancer | Solid TumorsUnited States
-
Nine Continents Medical, Inc.National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedOveractive BladderUnited States
-
Theranova, L.L.C.Stanford UniversityCompletedOveractive BladderUnited States
-
Pfizer's Upjohn has merged with Mylan to form Viatris...TerminatedOveractive BladderUnited States
-
Kenneth Peters, MDCompletedOveractive BladderUnited States
-
University of Michigan Rogel Cancer CenterCelgene CorporationCompletedBladder CancerUnited States
-
University of Michigan Rogel Cancer CenterGlaxoSmithKlineWithdrawnBladder Cancer | Urothelial CancerUnited States
-
EMKinetics, IncCompletedOveractive BladderUnited States
-
GlaxoSmithKlineCompletedOveractive BladderUnited States
-
William Beaumont HospitalsCompleted
-
Loyola UniversityAstellas Pharma US, Inc.Completed
-
Rahul ParikhTaiho Oncology, Inc.RecruitingBladder CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterCompletedBladder CancerUnited States
-
UNC Lineberger Comprehensive Cancer CenterNo longer available
-
Johns Hopkins UniversityRecruitingNon-Muscle Invasive Bladder CancerUnited States
-
Case Comprehensive Cancer CenterPfizerTerminatedRecurrent Bladder Cancer | Transitional Cell Carcinoma of the BladderUnited States
-
State University of New York at BuffaloAstellas Pharma IncWithdrawnUrinary Frequency/Urgency | Bladder Pain Syndrome | Bladder IrritableUnited States
-
BayerCompleted
-
Daniel George, MDAstraZenecaWithdrawn
-
University of Michigan Rogel Cancer CenterCelgene CorporationTerminatedBladder Cancer | Urothelial CancerUnited States
-
Washington University School of MedicineCompletedOveractive BladderUnited States
-
Loma Linda UniversityWithdrawnOveractive BladderUnited States